Ocean Biomedical, Inc.
OCEA
$0.04
-$0.0015-3.61%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -- | -- | 4.00K | 19.00K | 4.00K |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 588.00K | 802.00K | 1.05M | 1.28M | 1.11M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 224.00K | 240.00K | 225.00K | 500.00K | 1.00M |
Total Current Assets | 812.00K | 1.04M | 1.28M | 1.80M | 2.11M |
|
|||||
Total Current Assets | 812.00K | 1.04M | 1.28M | 1.80M | 2.11M |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 902.00K | 1.13M | 1.85M | 2.95M | 5.50M |
|
|||||
Total Accounts Payable | 799.00K | 862.00K | 926.00K | 991.00K | 933.00K |
Total Accrued Expenses | 15.10M | 16.38M | 16.25M | 16.81M | 15.25M |
Short-term Debt | 16.90M | 12.84M | 11.90M | 9.86M | 13.06M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 1.09M | 3.57M | 1.66M | 2.45M | 763.00K |
Total Other Current Liabilities | 1.09M | 3.57M | 1.66M | 2.45M | 763.00K |
Total Current Liabilities | 33.89M | 33.65M | 30.74M | 30.11M | 30.01M |
|
|||||
Total Current Liabilities | 33.89M | 33.65M | 30.74M | 30.11M | 30.01M |
Long-Term Debt | 5.57M | 5.16M | 4.79M | 4.44M | 4.12M |
Short-term Debt | 16.90M | 12.84M | 11.90M | 9.86M | 13.06M |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 59.06M | 60.41M | 59.07M | 44.18M | 62.13M |
Total Liabilities | 98.52M | 99.22M | 94.59M | 78.73M | 96.26M |
|
|||||
Common Stock & APIC | 107.92M | 107.73M | 107.55M | 107.27M | 105.29M |
Retained Earnings | -205.54M | -205.82M | -200.29M | -183.06M | -196.06M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -97.62M | -98.09M | -92.74M | -75.78M | -90.76M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -97.62M | -98.09M | -92.74M | -75.78M | -90.76M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -97.62M | -98.09M | -92.74M | -75.78M | -90.76M |
|